"10.1371_journal.pone.0058446","plos one","2013-03-04T00:00:00Z","Calpurnia Jayakumar; Punithavathi Ranganathan; Prasad Devarajan; Catherine D Krawczeski; Stephen Looney; Ganesan Ramesh","Department of Medicine and Vascular Biology Center, Georgia Health Sciences University, Augusta, Georgia, United States of America; Department of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, United States of America; Heart Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, Ohio, United States of America; Department of Biostatistics, Georgia Health Sciences University, Augusta, Georgia, United States of America","Conceived and designed the experiments: GR. Performed the experiments: CJ PR GR. Analyzed the data: SL PD. Contributed reagents/materials/analysis tools: PD CDK. Wrote the paper: CJ GR PD SL.","The authors have the following interests. Dr. Ramesh and Georgia Health Sciences University have submitted a provisional patent application for the use of urine semaphorin 3A for the early diagnosis of AKI. Dr. Devarajan is a co-inventor on patents related to NGAL as a biomarker of AKI, and is a consultant to Abbott Diagnostics and Biosite, Inc. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","Calpurnia Jayakumar","CJ",6,TRUE,1,3,2,4,TRUE,FALSE,FALSE,0,NA,FALSE
